supported by postdoctoral fellowship,Thammasat University(Rangsit Campus),Thailand;Kesara Na-Bangchang was received funding from Thammasat University under the project Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma(No.1/2556,dated October 12,2013);the National Research Council of Thailand(No.45/2561,dated September 10,2018);Kesara Na-Bangchang is supported by the National Research Council of Thailand under the Research Team Promotion grant(grant number NRCT 820/2563,dated November 12,2020).
Background:Secondary antimicrobial resistance bacterial(AMR)pneumonia could lead to an increase in mortality in COVID-19 patients,particularly of geriatric patients with underlying diseases.The comedication of current...
The coagulase-negative staphylococci (CoNS) group was considered saprophytic or rarely pathogenic for many years. Since the first case of septicemia caused by CoNS, there has been a progressive increase in the prevale...
Increasing antimicrobial resistance (AR) has become a severe problem of public health in the world, whereas control of the AR of bacteria will be based on investigation of the AR mechanism. Furthermore, understandin...
A total of 241 Escherichia coli (E. coli) isolates from 349 avian samples (292 from cloacae, 29 from feed and water, 28 from dust and padding) were collected from Northeast, South, North, and Central China in rece...